Literature DB >> 22094880

Neurocircuitry involved in the development of alcohol addiction: the dopamine system and its access points.

Bo Söderpalm1, Mia Ericson.   

Abstract

The brain reward system, and especially the mesolimbic dopamine pathway, plays a major role in drug reinforcement and is most likely involved in the development of drug addiction. All major drugs of abuse, including ethanol, acutely activate the mesolimbic dopamine system. Both this acute drug-induced dopamine elevation, the dopamine elevations observed after presentations of drug-associated stimuli and alterations of dopamine function induced by chronic drug administration are of importance. Whereas the mechanisms of actions for central stimulants, opioids and nicotine in their dopamine activating effects are fairly well established, the corresponding mechanisms with respect to ethanol have been elusive. Here we review the actions of ethanol in the mesolimbic dopamine system, focusing on ethanol's interaction with ligand-gated ion-channel receptors, opiate receptors, the ghrelin system and the possible involvement of acetaldehyde. Preclinical studies have provided the opportunity to dissect these interactions in some detail and although we do not fully comprehend the actions of ethanol there have been some great advances resulting in increased knowledge of the complexity of ethanol's mechanism of action in this system.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22094880     DOI: 10.1007/7854_2011_170

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  46 in total

Review 1.  Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.

Authors:  Megan M Yardley; Lara A Ray
Journal:  Addict Biol       Date:  2016-02-01       Impact factor: 4.280

2.  Allosteric modulation of the glycine receptor activated by agonists differing in efficacy.

Authors:  Nicole-Marie M Farley; S John Mihic
Journal:  Brain Res       Date:  2015-02-24       Impact factor: 3.252

3.  Ethanol Modulation is Quantitatively Determined by the Transmembrane Domain of Human α1 Glycine Receptors.

Authors:  Suzzane Horani; Evan P Stater; Pierre-Jean Corringer; James R Trudell; R Adron Harris; Rebecca J Howard
Journal:  Alcohol Clin Exp Res       Date:  2015-05-14       Impact factor: 3.455

4.  Defining and predicting short-term alcohol use changes during a smoking cessation attempt.

Authors:  Kristin M Berg; Megan E Piper; Stevens S Smith; Michael C Fiore; Douglas E Jorenby
Journal:  Addict Behav       Date:  2015-04-29       Impact factor: 3.913

Review 5.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

6.  Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers.

Authors:  Daniel J O Roche; Lara A Ray; Megan M Yardley; Andrea C King
Journal:  Curr Addict Rep       Date:  2016-02-03

7.  Nicotine enhances the locomotor stimulating but not the conditioned rewarding effect of ethanol in DBA/2J mice.

Authors:  Noah R Gubner; Christopher L Cunningham; Tamara J Phillips
Journal:  Alcohol Clin Exp Res       Date:  2015-01       Impact factor: 3.455

Review 8.  GABAA receptor polymorphisms in alcohol use disorder in the GWAS era.

Authors:  Mairi Koulentaki; Elias Kouroumalis
Journal:  Psychopharmacology (Berl)       Date:  2018-05-02       Impact factor: 4.530

9.  Reduced ethanol consumption by alcohol-preferring (P) rats following pharmacological silencing and deep brain stimulation of the nucleus accumbens shell.

Authors:  Jessica A Wilden; Kurt Y Qing; Sheketha R Hauser; William J McBride; Pedro P Irazoqui; Zachary A Rodd
Journal:  J Neurosurg       Date:  2014-01-24       Impact factor: 5.115

Review 10.  Peter Riederer "70th birthday" neurobiological foundations of modern addiction treatment.

Authors:  Christian Jacob
Journal:  J Neural Transm (Vienna)       Date:  2012-08-19       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.